NanoSyrinx, a spin-out from the Waterfield Lab at Warwick Medical School founded by Dr Joe Healey and Dr Nick Waterfield, announced on Monday that it had successfully raised a further £6.2M in seed financing. This builds on an initial fundraising in early 2020, and the company will use the funds to continue developing its platform – a novel biologic drug delivery system utilising genetically encoded “nanosyringes” – toward pre-clinical proof of concept over the next two years.

Further details here